Product Details
| Product Name: Retatrutide | CAS No.: 2381089-83-2 |
| Min. Order: 100mg | Purity: 99% HPLC |
| Supply Ability: 20kg | Release date: 2025/07/25 |
Retatrutide is an experimental drug for obesity developed by American pharmaceutical company Eli Lilly and Company. It is a triple hormone receptor agonist of GLP-1, GIP, and GCGR receptors. It has been shown to achieve a more than 24% mean weight reduction in non-diabetic obese or overweight adults during a phase 2 trial.
Company Profile Introduction
We are a company focusing on chemical products.
We can provide injection grade of peptides ( semaglutide,tirzepatide,Retatrutide HGH TB500 etc.)
Our guarantee:
Accurate content, no shortage. If shortage, refund!
High purity and reliable quality. If there are quality issues or purity below 98%, refund!
100% delivery. Customs detained and lost during transportation, resend！
We support PayPal commercial payments and provide protection for buyers
Expect your reply soon.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $10.00 |
VIP1Y
|
Shanghai Zheng Peptide Plastic Co., Ltd.
|
2026-07-09 | |
|
VIP2Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2026-07-09 | ||
| $180.00 |
VIP1Y
|
Deepharma Inc
|
2026-07-09 | |
| $5.00 |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2026-07-09 | |
| $1.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-09 | |
| $10.00 |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2026-07-09 | |
|
VIP3Y
|
Hangzhou Hyper Chemicals Limited
|
2026-07-09 | ||
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-07-09 | ||
| $9.00 |
VIP1Y
|
Guangzhou XinPeptide International Co.,Ltd
|
2026-07-09 | |
| $15.00 |
VIP1Y
|
Yiwu Jingpinhui Plastic Co., Ltd.
|
2026-07-09 |
China